Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Seelos Therapeutics, Inc. (SEELQ) vs Vincerx Pharma, Inc. (VINC)

Seelos Therapeutics, Inc. and Vincerx Pharma, Inc. are both Biotechnology companies. Seelos Therapeutics, Inc. is the larger, with a market value of $700.0K against $250.0K — 2.8× the size. Seelos Therapeutics, Inc. has the higher net margin (203.1% vs 0.00%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Seelos Therapeutics, Inc. leads on 8 and Vincerx Pharma, Inc. on 3.

Valuation

Metric SEELQ VINC Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B n/m 0.03 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 0.17 0.74
EV/Sales 0.50 n/m 10.73
Earnings yield 0.00% (29,060.50%) (28.84%)
Free cash flow yield 0.00% (32,262.57%) (23.03%)

Profitability

Metric SEELQ VINC Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (1,480.04%) 0.00% 0.00%
Net margin 203.13% 0.00% 0.00%
Free cash flow margin (659.09%) 0.00% 0.00%
Return on equity (10.86%) (3,136.43%) (57.72%)
Return on assets 57.34% (287.21%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric SEELQ VINC Biotechnology median
Revenue growth (TTM) (51.45%) — 5.64%
EPS growth (last fiscal year) 62.72% 58.07% —
Revenue growth, 5-year CAGR (22.63%) — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric SEELQ VINC Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.08 1.79 4.73
Net debt to EBITDA 0.09 0.17 0.96

Dividend

Metric SEELQ VINC Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric SEELQ VINC Biotechnology median
Market cap 700.00k 250.00k 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack